行情

NNVC

NNVC

NANOVIRICIDES
AMEX

实时行情|Nasdaq Last Sale

6.34
+0.18
+2.92%
盘后: 6.31 -0.03 -0.47% 19:59 08/07 EDT
开盘
6.13
昨收
6.16
最高
6.40
最低
6.11
成交量
36.04万
成交额
--
52周最高
19.20
52周最低
1.271
市值
6,755.40万
市盈率(TTM)
-2.3283
分时
5日
1月
3月
1年
5年

目标价格预测

分析师预测NNVC价格均价为0.6000,最高价位0.6000,最低价为0.6000。

EPS

NNVC 新闻

更多
NanoViricides, Inc. Raises $11.5 Million Through Public Offering After Positive Test Results For COVID-19 Drug
Newsfile · 07/23 16:48
NanoViricides To Participate In Panel Discussion At The B. Riley FBR Virtual Infectious Disease Summit Today, July 21, 2020
SHELTON, CT / ACCESSWIRE / July 21, 2020 / NanoViricides, Inc. (NYSE:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform,
Benzinga · 07/21 10:16
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds NanoViricides (NNVC) Investors of Proprietary Investigation into Possible Securities Law Violations, Encourages Investors and Persons Who May be Able to Assist Investigation to Contact Firm
GlobeNewswire · 07/20 23:10
Altium Capital Management Reports 7.2% Passive Stake In Nanoviricides
Benzinga · 07/20 19:38
Cashing in on coronavirus: Small biopharma company NanoViricides sees stock soar on treatment claims
As the coronavirus was spreading in China, a small biopharma company, NanoViricides, claimed it was close to clinical trials for a treatment. A CNBC investigation found the 15-year-old company has never tested a product in humans or made any revenue.
CNBC.com · 07/14 11:00
NanoVicirides Completes 1.37M Share Common Stock Offering at $8.40/Share
Benzinga · 07/13 10:32
Mid-Afternoon Market Update: Dow Falls Over 300 Points; Veritone Shares Spike Higher
Toward the end of trading Thursday, the Dow traded down 1.2% to 25,754.70 while the NASDAQ rose 0.39% to 10,532.55. The S&P also fell, dropping 0.55% to 3,152.65.
Benzinga · 07/09 18:33
Mid-Day Market Update: NASDAQ Turns Negative; Bed Bath & Beyond Shares Plunge
Midway through trading Thursday, the Dow traded down 1.89% to 25573.70 while the NASDAQ fell 0.79% to 10,409.73. The S&P also fell, dropping 1.50% to 3,122.45.
Benzinga · 07/09 16:12

所属板块

生物技术和医学研究
-0.18%
制药与医学研究
+0.08%

热门股票

代码
价格
涨跌幅

NNVC 简况

NanoViricides, Inc. is a nano-biopharmaceutical research and development company. The Company is engaged the discovery, development, and commercialization of drugs to combat viral infections using its nanomedicines technology. The Company provides nanoviricide technology, which enables direct attacks at multiple points on a virus particle. The nanoviricide technology is engaged in both attacking extracellular virus thereby breaking the reinfection cycle, and simultaneously disrupting intracellular production of the virus, thereby enabling complete control of a virus infection. The nanoviricide technology also simultaneously enables attacking the intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The Company’s lead product candidate is NV-HHV-101 in the HerpeCide program, as a skin cream for the treatment of shingles rash.
展开

微牛提供NanoViricides Inc(AMEX-NNVC)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的NNVC股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NNVC股票基本功能。